ImmunityBio (IBRX) Total Debt Growth (3y) (2017 - 2026)
ImmunityBio (IBRX) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
ImmunityBio |
7.55 Bn |
7.17 Bn |
43.97 Mn |
18.07% |
| Date | Value |
|---|
| Mar 31, 2026 |
18.07% |
| Sep 30, 2025 |
-5.39% |
| Jun 30, 2025 |
-0.59% |
| Mar 31, 2025 |
-1.44% |
| Sep 30, 2024 |
-4.27% |
| Jun 30, 2024 |
-5.99% |
| Mar 31, 2024 |
-19.66% |
| Dec 31, 2023 |
-16.73% |
| Sep 30, 2023 |
110.65% |
| Mar 31, 2023 |
560.36% |
| Sep 30, 2022 |
654.82% |
| Jun 30, 2022 |
588.65% |
| Mar 31, 2022 |
486.85% |
| Sep 30, 2021 |
423.44% |
| Jun 30, 2021 |
459.88% |
| Mar 31, 2021 |
404.36% |
| Dec 31, 2020 |
384.77% |
| Sep 30, 2020 |
195.71% |
| Mar 31, 2020 |
-26.22% |
| Dec 31, 2019 |
-34.79% |
